CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  2008-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.LEUKRES.2007.07.016PMID 17767956
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The prevalence and clinical implications of c‐kit expression in plasma cell myeloma

  2006cited by this paper
• A phase II trial of imatinib in patients with refractory/relapsed myeloma

  2006cited by this paper
• Phenotypic characterization of the human myeloma cell growth fraction.

  2005cited by this paper
• A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.

  2005cited by this paper
• KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and Their Clinicopathologic Correlation

  2005influential reference
• CD221 (IGF-1R) is aberrantly expressed in multiple myeloma, in relation to disease severity.

  2005cited by this paper
• Genetic Abnormalities and Patterns of Antigenic Expression in Multiple Myeloma

  2005cited by this paper
• [Expression of CD117 antigen on multiple myeloma and its significance].

  2004cited by this paper
• Rare KIT (CD117) expression in multiple myeloma abrogates the usefulness of imatinib mesylate treatment

  2004cited by this paper
• C-kit Receptor (CD117) Expression on Plasma Cells in Monoclonal Gammopathies

  2004cited by this paper
• Single versus double autologous stem-cell transplantation for multiple myeloma.

  2003cited by this paper
• CD117, but not lysozyme, is positive in cutaneous plasmacytoma.

  2003cited by this paper
• CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma.

  2003cited by this paper
• Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation.

  2002cited by this paper
• Immunohistochemical Identification of HER-2/ neu Overexpression and CD117 (c-kit) Expression in Multiple Myeloma

  2002cited by this paper
• Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy.

  2002cited by this paper
• Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.

  1998cited by this paper
• Expression of the CD117 antigen (C‐Kit) on normal and myelomatous plasma cells

  1996cited by this paper
• A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.

  1996cited by this paper
• A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

  1996cited by this paper

• Characterization of monoclonal gammopathy of undetermined significance progression to multiple myeloma through meta-analysis of GEO data

  2023cites this paper
• Biological Activity and Prognostic Significance of Common Surface Antigens in Multiple Myeloma

  2023cites this paper
• Immunophenotypic expression profile of multiple myeloma cases at a tertiary hospital in Nairobi Kenya

  2023influential citation
• Association of CD56 Positive with IGG-Type Multiple Myeloma

  2022cites this paper
• Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma

  2022cites this paper
• The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities

  2022cites this paper
• Prognostic Value of Association of Copy Number Alterations and Cell-Surface Expression Markers in Newly Diagnosed Multiple Myeloma Patients

  2022cites this paper
• Prognostic significance of bone marrow histological evaluation in patients with multiple myeloma

  2021cites this paper
• Multiparameter flow cytometry in plasma cell disorders: when in doubt, go with the flow

  2021cites this paper
• Syngeneic leukemia models using lentiviral transgenics

  2021cites this paper
• Clinical prognostic implications of EPB41L4A expression in multiple myeloma

  2020cites this paper
• Oral Cavity: an Inception to Diagnose Plasma Cell Myeloma. Case Report and Literature Review

  2020cites this paper
• Aspects of Phagocyte Function in Multiple Myeloma

  2019cites this paper
• Flow Cytometric Evaluation of Traditional and Novel Surface Markers for the Diagnosis of Plasma Cell Dyscrasias

  2019cites this paper
• CD56和（或）CD117表达在以硼替佐米为基础一线治疗的初诊多发性骨髓瘤患者中的预后意义

  2019cites this paper
• Plasma Cell Immunophenotyping Improve Prognostic Stratification of Multiple Myeloma Patients

  2018cites this paper
• Flow cytometric aberrancies in plasma cell myeloma and MGUS – correlation with laboratory parameters

  2018cites this paper
• The histopathology of myeloma in the bone marrow.

  2018cites this paper
• Association of CD117 and HLA-DR expression with shorter overall survival and/or progression-free survival in patients with multiple myeloma treated with bortezomib and thalidomide combination treatment without transplantation

  2018influential citation
• Expression of CD81 and CD117 in plasma cell myeloma and the relationship to prognosis

  2018cites this paper
• CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance

  2018cites this paper
• Diagnosis of chronic lymphoproliferative disorders by flow cytometry using four‐color combinations for immunophenotyping: A proposal of the brazilian group of flow cytometry (GBCFLUX)

  2017cites this paper
• Association between immunophenotypic markers and cytogenetic aberrations in Egyptian patients with plasma cell myeloma

  2017cites this paper
• The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients

  2017influential citation
• WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues

  2017cites this paper
• Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry.

  2017cites this paper
• Absence of both CD56 and CD117 expression on malignant plasma cells is related with a poor prognosis in patients with newly diagnosed multiple myeloma.

  2016influential citation
• Role of Flow Cytometry in the Diagnosis and Prognosis of Plasma Cell Myeloma.

  2016cites this paper
• Risk Stratification in Multiple Myeloma

  2016cites this paper
• Correlation between CD117+ myeloma plasma cells and hematopoietic progenitor cells in different categories of patients

  2015influential citation
• Flow cytometry in immunoglobulin light chain amyloidosis: Short review.

  2015cites this paper
• Antigen Expression Patterns of Plasma Cell Myeloma: An Association of Cytogenetic Abnormality and International Staging System (ISS) for Myeloma

  2015cites this paper
• Immunophenotype of Normal and Myelomatous Plasma-Cell Subsets

  2014cites this paper
• Nestin expression throughout multistep pathogenesis of multiple myeloma

  2014cites this paper
• Prognostic value of CD117 in cancer: a meta-analysis.

  2014cites this paper
• Prognostic value of CD 117 in cancer : a meta-analysis

  2014cites this paper
• Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma

  2013cites this paper
• Heterogeneity and Plasticity of Multiple Myeloma

  2013cites this paper
• Immunophenotyping in Multiple Myeloma and Others Monoclonal

  2013cites this paper
• Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells

  2013cites this paper
• Immunophenotyping in Multiple Myeloma and Others Monoclonal Gammopathies

  2013cites this paper
• CXCR4 is a good survival prognostic indicator in multiple myeloma patients.

  2013cites this paper
• Patterns of expression of CD56 and CD117 on neoplastic plasma cells and association with genetically distinct subtypes of plasma cell myeloma

  2012cites this paper
• Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside

  2012cites this paper
• Plasma Cell Disorders

  2012cites this paper
• Stemness of B-cell Progenitors in Multiple Myeloma Bone Marrow

  2012cites this paper
• A GEIL flow cytometry consensus proposal for quantification of plasma cells: Application to differential diagnosis between MGUS and myeloma

  2011cites this paper
• Role of flow cytometry of peripheral blood and bone marrow aspirates in early myeloma.

  2011cites this paper
• CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features

  2011cites this paper
• Flow Cytometry in Monoclonal Gammopathies Průtoková cytometrie u monoklonálních gamapatií

  2011cites this paper
• Multiple Myeloma: Molecular Biology, Diagnosis and Treatment

  2011cites this paper
• Untersuchungen zur Pathogenese und neuen Therapiemöglichkeiten bei Plasmazell-Dyskrasien

  2011cites this paper
• Immunophenotyping in multiple myeloma and related plasma cell disorders.

  2010cites this paper
• Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders

  2010cites this paper
• Multiple myeloma may include microvessel endothelial cells of malignant origin

  2010cites this paper
• Signaling of c‐kit in dendritic cells influences adaptive immunity

  2010cites this paper
• Detección molecular de enfermedad mínima residual en melanoma y otros tumores sólidos

  2009cites this paper
• [Molecular detection of minimal residual disease in melanoma and solid tumors].

  2009cites this paper
• Aspectos morfológicos da infiltração da medula óssea por condições exibindo diferenciação plasmocitária e gamopatia monoclonal

  2009cites this paper
• Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity

  2008influential citation
• Emerging functions of c-kit and its ligand stem cell factor in dendritic cells

  2008cites this paper
• Pathogenesis and progression of monoclonal gammopathy of undetermined significance

  2008cites this paper
• SPOTLIGHT REVIEW Pathogenesis and progression of monoclonal gammopathy of undetermined significance

  2008cites this paper